Diagnostic Health delisted from the Nasdaq:
This article was originally published in Clinica
Executive Summary
US diagnostic services and equipment company Diagnostic Health Services has been delisted from the Nasdaq stock market. This month the Dallas, Texas-based radiology and cardiology outsourcing service company announced that the planned merger between it and Medical Alliance would not go ahead. Second-quarter revenues slipped to $11 million from last year's $15.2 million, though the company reduced its loss (before charges relating to the failed merger), to $765,000, from $2.1 million loss in the same period last year.